Ajanta Pharma Shares Rise Amid Strong Earnings; Aurobindo Pharma Shares Decline
Ajanta Pharma's shares rose over 2%, reflecting strong financial growth with consolidated revenue reaching Rs 5,452.86 crore and net profit at Rs 1,056 crore for the year ending March 2026. Quarterly results also showed gains with revenue of Rs 1,625.96 crore and net profit of Rs 334.22 crore. Meanwhile, Aurobindo Pharma's shares declined 2.21%, despite a 3.35% quarterly revenue increase to Rs 9,150.35 crore and net profit rising to Rs 1,033.57 crore. Both companies are part of the Nifty Midcap 150 index and demonstrate ongoing operational expansion.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (67/100). Lens Score 37/100.
Outlets measured: moneycontrol, moneycontrol, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 13 Aug, 06:24 am. Other outlets followed.